Telaprevir

CHEMBL231813 Phase 4 Zugelassen Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

679.8 g/mol

LogP

4.2

Phase

4

This antiviral medication was used as part of combination therapy to treat chronic hepatitis C infection caused by genotype 1 of the virus. It works by blocking an enzyme (protease) that the hepatitis C virus needs to replicate. It has largely been replaced by newer, better-tolerated hepatitis C treatments.

Molekularmasse

679,8000 g/mol

LogP

4,20

TPSA

180,00 Å²

Lipinski-Regel der Fünf

Bestanden

Therapeutische Bereiche

HIV/AIDS Hepatitis C

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D-Struktur

SVG PNG

Cite this structure

Embed this structure

SMILES

CCC[C@H](NC(=O)[C@@H]1[C@H]2CCC[C@H]2CN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)c1cnccn1)C1CCCCC1)C(C)(C)C)C(=O)C(=O)NC1CC1

InChI

InChI=1S/C36H53N7O6/c1-5-10-25(29(44)34(48)39-23-15-16-23)40-33(47)28-24-14-9-13-22(24)20-43(28)35(49)30(36(2,3)4)42-32(46)27(21-11-7-6-8-12-21)41-31(45)26-19-37-17-18-38-26/h17-19,21-25,27-28,30H,5-16,20H2,1-4H3,(H,39,48)(H,40,47)(H,41,45)(H,42,46)/t22-,24-,25-,27-,28-,30+/m0/s1

Molecular Formula

C36H53N7O6

HBD / HBA

4 / 8

Rotierbare Bindungen

14

Schwere Atome

49

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Häufig gestellte Fragen

This antiviral medication was used as part of combination therapy to treat chronic hepatitis C infection caused by genotype 1 of the virus. It works by blocking an enzyme (protease) that the hepatitis C virus needs to replicate. It has largely been replaced by newer, better-tolerated hepatitis C treatments.

Yes, Telaprevir is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL231813. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 3010818. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Suchen Sie patientenfreundliche Informationen?

Telaprevir auf PillFYI

Struktur

Schnelldaten

Formel: C36H53N7O6

Externe Links

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Medizinischer Haftungsausschluss

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.